Clinical Trials Logo

Clinical Trial Summary

The study objective is to explore Deep Brain Stimulation (DBS) in two specific brain regions (Globus Pallidum, or GPI, plus the pedunculopontine nucleus, or PPN) for on medication freezing of gait (FoG) in Parkinsons Disease (PD). Hopefully, information gathered from these two brain regions after surgery will allow for the development of a personalized DBS system to address FoG. The primary outcome will be a comparison of the pre-operative number of FoG episodes in the laboratory during the FoG battery versus those 6 months post-DBS at the optimized device settings.


Clinical Trial Description

As a participant in the study you will have the following procedure performed:

A series of questions by interview, questionnaires, and checklists will be collected. In addition, basic information (such as age, sex, race) and psychiatric, medical, and family history, physical and neurological exam that will include measuring vital signs (heart rate and blood pressure). There will be a "Falls Diary' to complete (an account of falling incidents and the details). Specific testing will be done to evaluate the gait and balance which will be repeated throughout the study. A psychiatric evaluation of mood and emotion will be performed including a detailed psychological testing, consisting of perception, learning, and memory. These psychological assessments will be repeated at every study visit. An MRI and a CT scan will be performed to make sure of the exact location of the DBS implant. The study will end in 24 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02318927
Study type Interventional
Source University of Florida
Contact
Status Completed
Phase N/A
Start date January 2015
Completion date September 26, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05565443 - MR-guided Focused Ultrasound Plus GCase N/A
Completed NCT01941732 - Motor Response to Sildenafil in PD Phase 4
Active, not recruiting NCT04777331 - A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease Phase 2
Completed NCT02452125 - The Effects of Nicotine Chewing Gum in Parkinson's Disease N/A
Completed NCT02569021 - Battery-preserving Stimulation Patterns for Deep Brain Stimulation N/A
Completed NCT02676804 - Exercise Dosing Trial for Individuals With Parkinson's Disease N/A
Completed NCT02092181 - A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) Phase 4
Terminated NCT02249559 - Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease N/A
Completed NCT01163344 - Dance Exercise as Novel Complementary Therapy for Parkinson's Disease N/A
Recruiting NCT05539196 - A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Active, not recruiting NCT01417598 - BETA Study: Improving Balance Function in Elderly by Progressive and Specific Training and Physical Activity N/A
Withdrawn NCT01256905 - Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies N/A
Completed NCT01789385 - Anesthesia for Deep Brain Stimulation Phase 4
Completed NCT01360229 - Acupuncture for Fatigue in Parkinson's Disease N/A
Recruiting NCT02126475 - Temporal Expectations in Parkinson's Disease N/A